Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

To assess the value of quantitative vascular imaging by power Doppler US (PDUS) as a tool that can be used to stratify patient risk of joint damage in early seropositive RA while still biologic naive but on synthetic DMARD treatment.Eighty-five patients with seropositive RA of <3 years duration had clinical, laboratory and imaging assessments at 0 and 12 months. Imaging assessments consisted of radiographs of the hands and feet, two-dimensional (2D) high-frequency and PDUS imaging of 10 MCP joints that were scored for erosions and vascularity and three-dimensional (3D) PDUS of MCP joints and wrists that were scored for vascularity.Severe deterioration on radiographs and ultrasonography was seen in 45 and 28% of patients, respectively. The 3D power Doppler volume and 2D vascularity scores were the most useful US predictors of deterioration. These variables were modelled in two equations that estimate structural damage over 12 months. The equations had a sensitivity of 63.2% and specificity of 80.9% for predicting radiographic structural damage and a sensitivity of 54.2% and specificity of 96.7% for predicting structural damage on ultrasonography.In seropositive early RA, quantitative vascular imaging by PDUS has clinical utility in predicting which patients will derive benefit from early use of biologic therapy.

Original publication

DOI

10.1093/rheumatology/kev305

Type

Journal article

Journal

Rheumatology (oxford, england)

Publication Date

01/2016

Volume

55

Pages

89 - 93

Addresses

Kennedy Institute of Rheumatology Division, Imperial College.

Keywords

Metacarpophalangeal Joint, Humans, Arthritis, Rheumatoid, Synovitis, Disease Progression, Antirheumatic Agents, Imaging, Three-Dimensional, Ultrasonography, Doppler, Prognosis, Severity of Illness Index, Reproducibility of Results, Adolescent, Adult, Aged, Middle Aged, Female, Male, Young Adult